We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Expressed in 80% of Breast Cancers

By Biotechdaily staff writers
Posted on 05 May 2003
In preliminary findings, a research team has discovered that a new gene, BP1, is expressed in 80% of breast cancer patients. More...
The discovery was reported in the April 22, 2003, online issue of Breast Cancer Research.

The BP1 gene is an isoform previously discovered and cloned by Dr. Patricia Berg, associate professor of biochemistry and molecular biology at George Washington University Medical Center (GWU, Washington, DC, USA), who led the research. Dr. Berg has been studying the gene for 16 years.

"Because of these high numbers and our molecular studies, we believe that this gene may offer a useful new early target for breast cancer detection and therapy, and we must now conduct expedited research,” said Dr. Berg. In addition to Dr. Berg, the authors of the paper included scientists from the Children's National Medical Center, the University of Maryland Medical School, and Howard University College of Medicine (all in USA).

The GWU/Berg team also stated, "While the research into BP1 may impact all groups with breast cancer in that there was an overall higher expression rate, the research may prove especially helpful to African Americans, who disproportionately expressed the new gene.”


New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.